Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunocore Holdings plc

37.25
-0.7700-2.03%
Post-market: 37.250.00000.00%16:05 EDT
Volume:549.59K
Turnover:20.78M
Market Cap:1.87B
PE:-86.19
High:38.60
Open:37.82
Low:37.08
Close:38.02
Loading ...

Rpt-Immunocore - Qtrly Net Sales $84.1 Million

THOMSON REUTERS
·
26 Feb

Corrected-Immunocore - Qtrly Shr Loss $0.47 (Not Qtrly EPS $0.47)

THOMSON REUTERS
·
26 Feb

Earnings Flash (IMCR) Immunocore Posts Q4 Total Revenue of $84.1M, vs. FactSet Est of $84.5M

MT Newswires Live
·
26 Feb

Earnings Flash (IMCR) Immunocore Posts Q4 Net Loss $-0.47 a Share, vs. FactSet Est of $-0.18 Loss

MT Newswires Live
·
26 Feb

Immunocore - Qtrly Net Sales $84.1 Million

THOMSON REUTERS
·
26 Feb

Immunocore Hldgs Q4 EPS $(0.47) Misses $(0.24) Estimate, Sales $84.05M Beat $83.55M Estimate

Benzinga
·
26 Feb

Immunocore reports fourth quarter and full year 2024 financial results and provides a business update

GlobeNewswire
·
26 Feb

Immunocore Holdings PLC expected to post a loss of 26 cents a share - Earnings Preview

Reuters
·
24 Feb

Immunocore to report fourth quarter and full year 2024 financial results and host call on February 26, 2025

GlobeNewswire
·
19 Feb

Immunocore Gears Up to Report Q4 Earnings: Is a Beat in Store?

Zacks
·
17 Feb

Immunocore Holdings Price Target Maintained With a $100.00/Share by HC Wainwright & Co.

Dow Jones
·
27 Jan

Buy Rating Affirmed for Immunocore Holdings Amid Strategic Advancements and Promising Pipeline Developments

TIPRANKS
·
23 Jan

Exelixis Provides Preliminary 2024 Results and Outlook for 2025

Zacks
·
13 Jan

Wall Street Analysts Believe Immunocore (IMCR) Could Rally 113.13%: Here's is How to Trade

Zacks
·
13 Jan

Immunocore Holdings: Promising Pipeline and Strategic Advancements Position for Positive Outlook

TIPRANKS
·
13 Jan

Immunocore Holdings Outlines Strategic Priorities for 2025

TIPRANKS
·
11 Jan

FDA Updates EXEL on Previously Scheduled ODAC Meeting for Cabozantinib

Zacks
·
11 Jan

Immunocore Holdings Price Target Maintained With a $71.00/Share by Needham

Dow Jones
·
11 Jan

Immunocore Holdings Positioned for Growth with Strategic 2025 Priorities and Strong Financial Outlook

TIPRANKS
·
10 Jan

Immunocore announces 2025 strategic priorities at JPM Conference

TIPRANKS
·
10 Jan